[go: up one dir, main page]

GB2030043B - Injectable composition for the treatment of helminthiasis and clostridial diseases in animals - Google Patents

Injectable composition for the treatment of helminthiasis and clostridial diseases in animals

Info

Publication number
GB2030043B
GB2030043B GB7930236A GB7930236A GB2030043B GB 2030043 B GB2030043 B GB 2030043B GB 7930236 A GB7930236 A GB 7930236A GB 7930236 A GB7930236 A GB 7930236A GB 2030043 B GB2030043 B GB 2030043B
Authority
GB
United Kingdom
Prior art keywords
helminthiasis
animals
treatment
injectable composition
clostridial diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7930236A
Other versions
GB2030043A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orica Ltd
Original Assignee
ICI Australia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Australia Ltd filed Critical ICI Australia Ltd
Publication of GB2030043A publication Critical patent/GB2030043A/en
Application granted granted Critical
Publication of GB2030043B publication Critical patent/GB2030043B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB7930236A 1978-09-11 1979-08-31 Injectable composition for the treatment of helminthiasis and clostridial diseases in animals Expired GB2030043B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPD589878 1978-09-11
AUPD680378 1978-11-16

Publications (2)

Publication Number Publication Date
GB2030043A GB2030043A (en) 1980-04-02
GB2030043B true GB2030043B (en) 1983-02-23

Family

ID=25642248

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7930236A Expired GB2030043B (en) 1978-09-11 1979-08-31 Injectable composition for the treatment of helminthiasis and clostridial diseases in animals

Country Status (5)

Country Link
BE (1) BE878703A (en)
FR (1) FR2435252A1 (en)
GB (1) GB2030043B (en)
IE (1) IE48627B1 (en)
NZ (1) NZ191413A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3241113A1 (en) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen VACCINES WITH INGREDIENTS
US4781920A (en) * 1984-11-13 1988-11-01 American Cyanamid Company Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
AU728221B2 (en) * 1996-06-05 2001-01-04 Ashmont Holdings Limited Injectable compositions
CN1293918C (en) * 2003-03-13 2007-01-10 山东农业大学 Prepn of clostridium welchil toxoid vaccine and antitoxin serum
NZ574018A (en) * 2008-12-24 2011-03-31 Bomac Research Ltd Clostridial vaccine comprising levamisole
US8313752B2 (en) 2009-04-14 2012-11-20 Merial Limited Macrocyclic lactone combination compositions, vaccines and methods for producing same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB958564A (en) * 1959-11-23 1964-05-21 Wellcome Found Vaccines containing clostridium perfringens ª‰-toxoid
GB1024369A (en) * 1963-08-12 1966-03-30 Internat Serum Company Ltd Antiserum preparations
GB1143545A (en) * 1965-03-25 1969-02-26 Wellcome Found Injectable vaccine emulsions
US3639577A (en) * 1968-02-23 1972-02-01 Haver Lockhart Lab Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
AU450030B2 (en) * 1970-06-25 1974-06-12 Ici Australia Limited Injectable solutions of l-tetramisole salts
AU440746B2 (en) * 1970-06-25 1972-01-06 Ici Australia Limited Injectable solutions of l tetramisole salts
US3956488A (en) * 1973-09-27 1976-05-11 Merck & Co., Inc. Compositions and methods for the treatment of helminthiasis

Also Published As

Publication number Publication date
IE791639L (en) 1980-03-11
BE878703A (en) 1980-03-10
FR2435252A1 (en) 1980-04-04
IE48627B1 (en) 1985-04-03
NZ191413A (en) 1981-10-19
GB2030043A (en) 1980-04-02
FR2435252B1 (en) 1983-04-29

Similar Documents

Publication Publication Date Title
GB2013493B (en) Skin treatment products
ZA793755B (en) Skin treatment compositions
GB2013495A (en) Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
ZA764213B (en) Improvements in and relating to the treatment of waste
GB2011786B (en) Composition for cleansing the skin
JPS54135776A (en) Pharmaceutical composition and method
JPS54145645A (en) *mmbenzoyllphenoxy**22propionic acid derivative and medicine
IL58017A (en) Injectable composition for treating cardio-vascular diseases
JPS54113442A (en) Treating agent of hyperlipoid disease
JPS5225036A (en) Cattle disease treating composition and treating method
JPS5540670A (en) Novel pyrimidone derivative*its manufacture and its medical composition
JPS557290A (en) Oxamic acid derivative and medical composition
GB2020661A (en) 2-substituted-4-aryl-5-thiazole-carboxylic acids and theirderivatives useful as safening agents
GB2030043B (en) Injectable composition for the treatment of helminthiasis and clostridial diseases in animals
GB2038625B (en) Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
ZA793364B (en) Composition for treating human hair
DE2963141D1 (en) New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them
JPS54140714A (en) Skin treating composition
JPS54148787A (en) Substituted alkanyllazolyloximeecarbamate* its manufacture and use as insecticide* mitecide and nematodicide
JPS5535086A (en) Thazine derivative and medical composition
PT69270A (en) Process for preparing novel androstadienes and their use as dermatological agents
JPS5567361A (en) Encircling body for treating portion material to be worked
PT70556A (en) Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
JPS5555155A (en) 66methoxyy22acetylnaphthaleneoxime derivative*its manufacture and medical composition
JPS552698A (en) Thienooor furopyridone derivative* its manufacture and therapeutic composition containing it

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19980831